About Morphium

Who this site is for

Morphium was built for a specific audience: clinicians, medical researchers, graduate students in the life sciences, and healthcare professionals who need concise, accurate, and actionable analysis of current medical research. We also serve well-informed patients and caregivers who want to understand the science behind treatment decisions without the hype.

If you regularly read journals such as The New England Journal of Medicine, The Lancet, JAMA, or Nature Medicine — or if you wish you had more time to keep up with them — you are exactly who we write for. Our readers value clarity over jargon and practical application over academic performance.

Topics we cover

We focus on areas where research directly affects clinical decisions and patient outcomes. Every article is anchored in a problem–solution framework: we identify a common clinical or methodological challenge, then present the evidence-based solution — and often highlight mistakes to avoid. Our core categories include:

• Clinical trial methodology — bias, randomization pitfalls, surrogate endpoints, and common statistical errors.
• Therapeutic updates — new drug classes, repurposed agents, and changes in standard-of-care backed by phase III data.
• Diagnostic accuracy — sensitivity, specificity, likelihood ratios, and how test characteristics shift with disease prevalence.
• Systematic reviews & meta-analyses — how to interpret forest plots, heterogeneity, and publication bias.
• Research integrity — retractions, data fabrication, p-hacking, and how to spot red flags in published studies.
• Guideline changes — when and why major organizations (WHO, FDA, ESC, ASCO) revise their recommendations.

We avoid breaking news or press-release summaries. Instead, we wait for the full publication, read the supplementary material, and then deliver analysis that stays relevant for months — not hours.

Editorial standards

Trust is the only currency in medical publishing. Every article on Morphium adheres to three non-negotiable principles:

• Verify facts against primary sources. We do not cite abstracts alone, press releases, or second-hand reports. Every claim is checked against the original peer-reviewed paper, trial registry entry, or regulatory document.
• Update when practice changes. Medical knowledge evolves rapidly. If a major trial contradicts a conclusion we published, we revise the article within 30 days and add a clear update note. We do not quietly delete or rewrite history.
• Disclose uncertainty. We explicitly state when evidence is weak, when effect sizes are small, or when a recommendation is based on expert opinion rather than high-quality RCTs. Certainty is rare in medicine; we never pretend otherwise.

We do not accept sponsored posts, paid placements, or content written by pharmaceutical marketing teams. Our editorial independence is absolute. Authors and editors are required to disclose any financial or academic conflicts; if a conflict exists, that author does not write on the relevant topic.

Our editorial approach: problem–solution & common mistakes

Rather than simply summarizing a study, we frame every article around a real-world problem. For example: “Why do so many sepsis trials fail to show benefit — and what can researchers do differently?” or “Three common misinterpretations of number needed to treat (NNT) that lead to flawed clinical decisions.” We then walk through the evidence, explain the reasoning, and end with actionable takeaways. This structure helps readers immediately apply the insight to their own work or practice.

We also dedicate a regular series to Mistakes to Avoid — short, focused pieces that dissect a single error (e.g., using per-protocol analysis when intention-to-treat is required, or misapplying Bonferroni correction in exploratory analyses). These are designed to be shared with colleagues and used in journal clubs.

Contact

---